GGM Financials’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$786K Buy
656
+4
+0.6% +$4.09K 0.3% 37
2026
Q1
$599K Sell
652
-99
-13% -$100K 0.28% 44
2025
Q4
$807K Buy
751
+1
+0.1% +$956 0.39% 33
2025
Q3
$572K Buy
750
+2
+0.3% +$1.49K 0.29% 40
2025
Q2
$583K Buy
748
+1
+0.1% +$777 0.34% 38
2025
Q1
$617K Buy
747
+1
+0.1% +$832 0.42% 35
2024
Q4
$576K Buy
746
+1
+0.1% +$828 0.61% 33
2024
Q3
$660K Buy
745
+26
+4% +$23.4K 0.57% 31
2024
Q2
$651K Buy
+719
New +$575K 0.6% 30

Other funds holding LLY

GGM Financials's LLY Position: Q2 2026 in Review

GGM Financials increased its Eli Lilly (LLY) stake by 0.61% in Q2 2026, buying an estimated $4.09K and bringing the position to 656 shares worth $786K. The position accounts for 0.3% of the portfolio, ranked #37.

GGM Financials first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $807K in Q4 2025. 1,716 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GGM Financials held 656 shares of Eli Lilly worth $786K as of Q2 2026.
  • GGM Financials bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.3% of GGM Financials's portfolio in Q2 2026, its #37 holding.
  • GGM Financials first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • GGM Financials's Eli Lilly position peaked at $807K in Q4 2025.
  • 1,716 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.